COVID-19: Chloroquine and hydroxychloroquine research, 8 May 2020
Date
2020Document Number
PAHO/EIH/KT/COVID-19/20-0002
Metadata
Show full item recordAbstract
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical trials testing the efficacy and safety of several medicines for COVID-19, as of the date of this document, there is a lack of quality evidence to demonstrate chloroquine and/or hydroxychloroquine are effective in the treatment of COVID-19. Evidence is recently emerging via small studies with sub-optimal methodologies that are conflicting.
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (PAHOUnited StatesWashington, D.C., 2020)In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing ...
-
Mello, Vinícius de; Pereira, Vinícius de Paula; Rodrigues, João Paulo Vilela; Penteado, Suelem Tavares da Silva; Pereira, Leonardo Régis Leira; Varallo, Fabiana Rossi (2022)[RESUMO]. Objetivo. Identificar eventos adversos no sistema nervoso central (SNC) potencialmente associados ao uso de medicamentos para profilaxia ou tratamento da COVID-19, bem como caracterizar os indivíduos acometidos. ...
-
Rosa, Sandro G. Viveiros; Santos, Wilson C. (2020)[ABSTRACT]. The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were ...